Lifeward regains Nasdaq audit committee compliance with three new appointees

Lifeward Ltd.

Nasdaq confirmed on March 30, 2026 that Lifeward now complies with Listing Rule 5605(c)(2)(A) after audit committee appointments.
Deficiency arose from resignation of director Hadar Levy; cure period allowed until February 2027 or sooner.
Appointed to audit committee: Moshe Rozenbaum, William Mark Sigsbee, Yehuda Reznick.
The matter is now closed with no further action required.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.